DocDollars

Avion Pharmaceuticals

GA · United States · Reporting entity ID 100000005590

Total reported 2019–2025
$1.40M
#1,177 of 2,960 reporting companies — 0% of all reported industry payments
$874K in general payments across 47,840 records, plus $530K in research funding across 68 records.

How it breaks down

General payments $873,656
Research funding $529,764

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Avion Pharmaceuticals reported $1.40M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,177 of 2,960 reporting companies. 38% of that was research funding and 62% general payments such as consulting, speaking, food and travel. 47,840 general payment records and 68 research records were filed.

Common questions about Avion Pharmaceuticals

How much has Avion Pharmaceuticals paid US doctors?

Avion Pharmaceuticals reported $1,403,420 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $873,656 in general payments, $529,764 in research funding.

How does Avion Pharmaceuticals rank among drug and device companies?

It ranks #1,177 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Avion Pharmaceuticals mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.